Revolutionizing Healthcare: Enhanced Acupuncture Strategy Proves Cost-Effective for Chronic Low Back Pain in Older Adults
A groundbreaking economic evaluation from the BackInAction trial reveals that an advanced acupuncture approach for older adults suffering from chronic low back pain is not only beneficial but also financially prudent. This study, published in the prestigious Spine journal, challenges traditional clinical trial perspectives.
The BackInAction research team, led by renowned experts, previously demonstrated that acupuncture significantly alleviates pain and disability in patients aged 65 and above. Now, a deeper analysis showcases the treatment's substantial value to the healthcare system.
The cost-effectiveness study, conducted by Patricia Herman of the RAND Corporation, analyzed data from 672 participants across three major healthcare systems. It compared three treatment strategies: standard acupuncture with usual medical care, enhanced acupuncture with up to six maintenance sessions, and usual care alone.
The findings are remarkable: enhanced acupuncture reduced annual healthcare costs by an average of $491 per participant and Medicare-reimbursed costs by $421 per participant compared to standard care. This significant reduction in non-acupuncture healthcare utilization drives the cost savings.
BackInAction, an NIH Collaboratory Trial, was led by co-principal investigators Lynn DeBar and Andrea Cook. The study's impact extends beyond financial savings, as participants in the enhanced acupuncture group experienced:
- Substantial improvements in quality-adjusted life-years, a key indicator of health-related quality of life.
- A remarkable 18.5 percentage-point increase in participants achieving clinically significant disability score improvements.
Despite being slightly more expensive than usual care, the enhanced acupuncture strategy's cost-effectiveness ratio of approximately $53,000 per quality-adjusted life-year suggests it is a financially sound choice for Medicare and the healthcare sector.
This pragmatic clinical trial's findings are particularly relevant given the Medicare program's 2020 decision to cover acupuncture for chronic low back pain. The study indicates that the current Medicare benefit, including maintenance sessions, aligns with the most cost-effective and beneficial care for this demographic.
By encompassing diverse healthcare settings and older adults with multiple medical conditions, the BackInAction trial's results are highly generalizable. They provide valuable insights for future treatment policies, aiming to improve the lives of the millions of older Americans grappling with chronic pain.
BackInAction received support from the NIH Pragmatic Trials Collaboratory, funded by the NIH HEAL Initiative and the National Center for Complementary and Integrative Health. For more information, visit the official website: https://rethinkingclinicaltrials.org/demonstration-projects/acuoa/
